Results for "Understanding Pharmaceutical Distribution"
HDA Survey Results Indicate More Preparation Necessary for Connecting EPCIS-Enabled Systems Before DSCSA Deadline
Data released by the Healthcare Distribution Alliance (HDA) indicate more preparation is needed to ensure all healthcare supply chain partners are ready to meet the requirements of the Drug Supply Chain Security Act (DSCSA). HDA’s latest EPCIS Implementation Benchmarking Survey provides a final report on supply chain partners’ progress toward the November 27, 2023, deadline to connect data systems to exchange serialized transaction data for all pharmaceuticals.
HDA Statement on FDA Enforcement Discretion for the DSCSA’s Final Implementation Requirements
The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) announcement that it plans to exercise enforcement discretion for the Drug Supply Chain Security Act’s (DSCSA) final implementation requirements.
Pharmaceutical Distributors are at the Forefront of Cold Chain Logistics
As the fight against the coronavirus pandemic continues, the successful development of effective COVID-19 vaccines will represent a pivotal moment in our country’s efforts to end this public health crisis. However, the discovery of a vaccine is just the first step of many to ensure these critical medicines are widely accessible to providers and their patients.